New group therapy aims to quiet voices in schizophrenia

NCT ID NCT07266376

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 15-session group therapy program for people with schizophrenia who still hear voices despite medication. The program combines several proven strategies to help reduce how often the voices occur and how much distress they cause. Researchers will compare the therapy group to a control group to see if it improves symptoms like anxiety and depression. The goal is to offer a non-drug option for managing treatment-resistant auditory hallucinations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
integrative group therapy (behavioral intervention)
What this could lead to
If it works, this program could offer a practical, non-drug way to reduce the frequency and distress of voices for people with schizophrenia who don't respond to medication.
What could go wrong
This is a relatively small, early-stage trial with 116 participants. The therapy is time-intensive (15 weekly sessions) and may not work for everyone. Results may not apply to all people with schizophrenia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENTAL DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Public Mental Health Institution of Guadeloupe

    Les Abymes, 97139, Guadeloupe

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.